HDAC inhibitors and Alzheimer's; New gene for breast cancer; Genetic variants may help guide rheumatoid arthritis therapy;

> Studying HDAC inhibitors in Alzheimer's, investigators at Scripps "found evidence that better synapse growth was associated with less specific inhibition of Class 1 HDACs. There was a clear correlation between synapse building-- which may lead to improved network power--and memory restoration by the different HDAC inhibitors." Release

> A study led by Women's College Hospital researcher Dr. Mohammad Akbari has identified a new breast cancer gene. Release

> Scientists at The University of Manchester have pointed to specific genetic variants that may eventually be used to guide treatment of rheumatoid arthritis. Release

Suggested Articles

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.

Combining a DYRK1A inhibitor with popular GLP-1 receptor agonists regenerates insulin-producing beta cells, Mount Sinai scientists found.

Arming a peptide taken from the virus that causes foot-and-mouth disease in cows with the payload tesirine shows promise against pancreatic cancer.